Resources
Intelligent Drug Screening
Material and information relating to our Intelligent Drug Screening solution. If you have a specific request, please contact us.
Frequently Asked Questions
Sweat testing can detect a wide range of drugs, including cannabis (THC), cocaine, methamphetamines, opiates, and more. The specific drugs detectable depend on the testing panel on the cartridge.
A small, tamper-evident drug screening cartridge quickly collects ten fingerprint sweat samples, which are then analyzed in our DSR-Plus reader for precise on-screen results in minutes. Find out more here.
Our drug screening device tests for “fitness for duty” on the day and has a detection window of 16-24 hours. The detection window for drugs in sweat can vary depending on factors such as the drug’s half-life, the individual’s metabolism, and the specific testing method.
Sweat drug screening is considered highly accurate and has comparable performance characteristics to saliva and urine.
External factors, such as temperature, humidity, and physical activity, can influence sweat production. However, our screening method is designed to account for these variables and ensure accurate results.
Yes, sweat screening is suitable for post-accident and reasonable suspicion testing, as it can provide insights into recent drug use within the defined detection window.
Sample collection takes <1 min. Results are displayed in up to 10 minutes if you are conducting a single test as it takes approximately this long for the chemical reaction to take place once the sweat samples are collected.
However, there is a batch test functionality that can reduce the time per test to <3 min.
Comprehensive training of application and collection of specimens is delivered by Intelligent Bio Solutions. Virtual and in person delivery options are available. The training and certification for collection of specimens by sweat will allow nominated personnel to administer sweat drug screening for your organization.
2 years from the date of manufacture.
Yes, non-negative screening test results may be verified using our back-to-lab confirmation service, provided by an independent, accredited laboratory. Our fingerprint collection kit for laboratory analysis is used to collect and return two sets of fingerprint samples for laboratory testing.
Testing and record keeping processes comply with applicable privacy legislation. All drug testing is performed in an area appropriate for the testing type to ensure the outcome is only known to the person and authorised tester, and not those waiting to be tested.
Results from laboratory confirmation are emailed directly by our partner laboratory to the nominated contact at your organisation with a unique password to download the results.
Yes, we offer in person and virtual demonstrations. Complete the form on this page to request a demonstration.
Latest Drug Screening News

What Intelligent Bio Solutions Does and The Problem It Solves
Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a med tech company focused on delivering intelligent, rapid, non-invasive testing solutions. The company’s flagship product, the Intelligent Fingerprinting Drug Screening System, analyzes fingerprint sweat to detect drug use, supporting workplace safety across safety-critical industries, government and law-enforcement settings. INBS’ story is about more than an alternative approach…

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
NEW YORK, July 23, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has addressed all the cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This follows the Company’s recent completion of independent third-party penetration…

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
NEW YORK, July 21, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the completion of precision testing, a key component of the Company’s FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for detection…